Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hübner

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|October 8, 2009
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligandsDaniela Huber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725Stefan Löber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Cyclic amidines as benzamide bioisosteres: EPC synthesis and SAR studies leading to the selective dopamine D4 receptor agonist FAUC 312Jürgen Einsiedel, Harald Hübner, Peter Gmeiner
Archiv Der Pharmazie|June 14, 2005
Chirospecific and subtype selective dopamine receptor binding of heterocyclic methoxynaphthamide analogsLaura Bettinetti, Harald Hübner, Peter Gmeiner
Journal of Medicinal Chemistry|May 24, 2011
Bivalent dopamine D2 receptor ligands: synthesis and binding propertiesJulia Kühhorn, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|March 28, 2006
Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtypeStefan Löber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356Markus Bergauer, Harald Hübner, Peter Gmeiner
Journal of Medicinal Chemistry|September 16, 2010
Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptorsMarika Skultety, Harald Hübner, Stefan Löber, et al.
Journal of Medicinal Chemistry|October 16, 2004
Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13)Holger Bittermann, Jürgen Einsiedel, Harald Hübner, et al.
Bioorganic & Medicinal Chemistry|July 2, 2017
Potent haloperidol derivatives covalently binding to the dopamine D2 receptorTobias Schwalbe, Jonas Kaindl, Harald Hübner, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|October 8, 2009
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligandsDaniela Huber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725Stefan Löber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Cyclic amidines as benzamide bioisosteres: EPC synthesis and SAR studies leading to the selective dopamine D4 receptor agonist FAUC 312Jürgen Einsiedel, Harald Hübner, Peter Gmeiner
Archiv Der Pharmazie|June 14, 2005
Chirospecific and subtype selective dopamine receptor binding of heterocyclic methoxynaphthamide analogsLaura Bettinetti, Harald Hübner, Peter Gmeiner
Journal of Medicinal Chemistry|May 24, 2011
Bivalent dopamine D2 receptor ligands: synthesis and binding propertiesJulia Kühhorn, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|March 28, 2006
Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtypeStefan Löber, Harald Hübner, Peter Gmeiner
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356Markus Bergauer, Harald Hübner, Peter Gmeiner
Journal of Medicinal Chemistry|September 16, 2010
Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptorsMarika Skultety, Harald Hübner, Stefan Löber, et al.
Journal of Medicinal Chemistry|October 16, 2004
Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13)Holger Bittermann, Jürgen Einsiedel, Harald Hübner, et al.
Bioorganic & Medicinal Chemistry|July 2, 2017
Potent haloperidol derivatives covalently binding to the dopamine D2 receptorTobias Schwalbe, Jonas Kaindl, Harald Hübner, et al.
Pageof 17